This Issue At A Glance

Although Descemet's stripping endothelial keratoplasty (DSEK) is more expensive to perform compared to the traditional full-thickness penetrating keratoplasty (PK) for endothelial disease, Bose et al (p. 464) found that DSEK should be the preferred treatment alternative from a cost-effectiveness perspective. The study demonstrated that for a given budget, it was possible to achieve greater quality adjusted life years (QALY) gains by providing DSEK to as many patients as possible – and no intervention to others – rather than providing PK. The retrospective cohort study involved 171 patients who underwent PK (Read more...)

Full Story →